Regulatory compliance for a keratosis pilaris body lotion depends on your target market (US, EU, Canada, etc.) and your product claims. In the US, a KP lotion that claims to "exfoliate" or "smooth texture" is a cosmetic and requires no pre-market FDA approval, but you must ensure your formula is safe and properly labeled, and you must register your facility and product with the FDA before sale. In the EU, the lotion is also a cosmetic but must be notified on the CPNP (Cosmetic Products Notification Portal) before you sell it, and your hydroxy acid concentrations must comply with Annex III restrictions. Testing requirements—stability, preservative efficacy, irritation—are typically not legally mandated but are industry standard and reduce liability risk.
In the United States, the regulatory pathway for a KP body lotion is straightforward if you avoid drug claims. The key distinction: cosmetics clean, beautify, or modify appearance; drugs diagnose, cure, mitigate, treat, or prevent disease. If your lotion claims to "help reduce the appearance of rough texture on KP-prone skin" or "supports skin smoothness," it is a cosmetic. If it claims to "treat keratosis pilaris" or "cure KP," it becomes a drug and triggers much stricter requirements (e.g., FDA approval of active ingredients as "new drug substances," submission of safety and efficacy data). Most indie founders stay in cosmetic territory because the bar is lower: you must register your manufacturing facility with the FDA (free, online, annual form) and notify the FDA of your finished product ingredients within 30 days of US introduction. You do not need pre-market approval, but you are liable if the product causes injury or makes false claims. Your cosmetic label must include: ingredients in descending order by weight (using INCI names), net weight, manufacturer name and address, and a warning statement if needed (e.g., "May cause irritation; discontinue use if irritation occurs"). You do not need to list claim substantiation (studies proving efficacy), but if you make any claim in marketing, you should be prepared to defend it; the FTC scrutinizes substantiation of beauty claims, and unsubstantiated claims can trigger warning letters.
In the European Union, the pathway is also cosmetic but more prescriptive. You must comply with the Cosmetics Regulation (EC 1223/2009), which means: (1) Notifying your product on CPNP (Cosmetic Products Notification Portal), which requires registration of your company, product details, and a full ingredient list at least 10 days before you place the lotion on the market (notification takes ~2 weeks). (2) Confirming that all ingredients and concentrations comply with Annex III (restricted substances) and Annex IV (banned substances). For hydroxy acids, Annex III specifies that AHA active ingredients (glycolic acid, lactic acid, etc.) must not exceed 10% w/w in rinse-off products and 3% w/w in leave-on products, and the pH must be ≥ 3.5 for leave-on products. If your KP lotion is a leave-on product (which it is) with glycolic acid, your concentration must be ≤ 3% (a significant restriction compared to the US). Some brands formulate dual versions: a 7% glycolic lotion for US/Canada/rest of world, and a 3% glycolic formula for EU (which requires a separate CPNP notification and different SKU). (3) Ensuring your formula does not contain banned ingredients or unapproved colorants. (4) Labeling in the local language of each country where you sell.
In other regions: Canada treats cosmetics similarly to the US but with slightly different labeling and ingredient restrictions (via Health Canada). Australia requires compliance with the Australian Consumer Law and ACNC standards. If you plan international expansion, discuss regulatory scope with your chemist upfront; if you want a formula compliant in both the US (10% glycolic) and EU (3% glycolic), you will need two separate formulas, which doubles development cost.
Now, testing and safety. Legally, stability and preservative efficacy testing are not mandated for cosmetics in the US or EU, but they are industry standard and protect your brand from liability. A stability test (typically at 40 °C / 75% RH for 8–12 weeks, plus room temperature storage for the same duration) evaluates whether your formula separates, discolors, thickens, or loses potency over time. This is especially critical for hydroxy acid lotions because acids can degrade emulsifiers or active ingredients if not buffered properly. If you claim a 24-month shelf life, you should have data backing it (at minimum, a 12-week accelerated test showing no adverse changes). Preservative efficacy challenge tests (PECT) verify that your preservative system (e.g., phenoxyethanol + methylisothiazolinone) actually prevents microbial growth under stress conditions. For a body lotion, a basic PECT (challenge with standardized bacteria and fungi, measure log reduction over time) costs $800–$1,500 and takes 2–3 weeks. These tests are typically run by contract labs (separate from your formulation lab) and are included in your chemist's development scope or outsourced as an additional fee.
Human safety and irritation testing is not legally required for cosmetics but is prudent. Common tests include: (1) Skin irritation (patch test or repeat insult patch test / RIPT), which assesses whether the formula causes redness, itching, or sensitization after repeated application. A RIPT involves ~30 volunteers applying the lotion under occlusion for 2 weeks, then a 2-week rest, then re-exposure to detect sensitization. Cost $1,500–$3,000, duration 4–6 weeks. (2) Eye irritation, if there is a risk of splashing (unlikely for a body lotion, so often skipped). (3) Microbiological testing of the finished product (plate counts of bacteria and fungi), which is a basic QC check to ensure the product was not contaminated during manufacturing. Cost $200–$400, duration 1 week.
For a body lotion with 7–8% glycolic acid, the risk profile is moderate: glycolic acid can be irritating, especially on sensitive skin, so skin irritation testing is recommended. Many brands commission a RIPT before launch, particularly if they plan to make claims like "dermatologist-tested" or "clinically proven to reduce roughness." However, many indie founders skip RIPT to save cost and time (4–6 weeks delay, $2,000+ fee) and instead rely on the chemist's formulation expertise, preservative testing, and early customer feedback (e.g., a beta test with 50–100 users). This is a risk trade-off: faster to market, but higher liability if users experience unexpected irritation.
Claim substantiation is a regulatory consideration in the US and increasingly in the EU. If you claim your lotion "smooths texture" or "improves skin appearance in 2 weeks," the FTC expects competent and reliable evidence supporting the claim. For indie brands, this typically means: (1) Relying on ingredient literature (e.g., published studies on glycolic acid's exfoliating effects, which are well-established). (2) Commissioning a small in-vivo study with 20–30 volunteers applying the lotion for 4–8 weeks and measuring texture improvement via photos or subjective scoring. Cost $3,000–$8,000, duration 8–12 weeks. (3) Consumer testimonials and before-and-after photos, though these require careful FTC compliance (must represent typical results, must disclose if compensation was involved, etc.). Most indie brands use ingredient-based substantiation (e.g., "Contains 8% glycolic acid, a proven exfoliant,") and consumer reviews rather than commissioning an independent clinical study, which is expensive and time-consuming. However, larger retailers (Sephora, Ulta) may request clinical data before placing your product on shelves.
Documentation your chemist should prepare: (1) Safety assessment or cosmetic risk assessment (CRA), a dossier evaluating the safety of your formula based on ingredient toxicology, concentrations, and intended use. This is required for EU CPNP registration and recommended for US launches. Cost $500–$1,500. (2) Product specification sheet with INCI, stability data, and shelf-life claim. (3) Regulatory compliance memo confirming the product is a cosmetic (not a drug), ingredient compliance for your target market, and labeling requirements. (4) If you conduct stability or RIPT testing, reports from the testing lab.
Timeline for compliance before launch: If you are launching in the US only and are not commissioning irritation testing, you can launch 2–4 weeks after your formula is finalized (time for CPNP notification and facility registration if needed). If you want stability testing before launch, add 8–12 weeks. If you want RIPT testing, add 4–6 weeks (can run in parallel with stability). If you are launching in the EU, add 2–3 weeks for CPNP review (though notification is generally accepted on receipt) and confirm Annex III compliance with your chemist; if your formula exceeds EU concentration limits, add 4–8 weeks to reformulate and re-test.
Common compliance mistake: Assuming a formula that passes US cosmetic registration will automatically work in the EU, Canada, and other regions without reformulation. Hydroxy acid concentration caps, banned ingredients, and labeling requirements vary significantly. If you plan international expansion, budget for regional formula variants and longer approval timelines. Work with a chemist who has multi-market experience (ask: "Have you launched a product in both the US and EU? What changes were needed?") to avoid expensive surprises post-launch.
Ingredients in this answer: Glycolic Acid · Lactic Acid · Phenoxyethanol
Read the full guide on How to Find a Cosmetic Chemist for KP Body Lotion →